vs
CS Disco, Inc.(LAW)与PUMA BIOTECHNOLOGY, INC.(PBYI)财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是CS Disco, Inc.的1.8倍($75.5M vs $41.2M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs 11.3%),PUMA BIOTECHNOLOGY, INC.自由现金流更多($14.4M vs $255.0K),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs 7.6%)
CS Disco, Inc.是一家领先的法律科技企业,开发面向法律从业者的云原生软件产品,涵盖电子取证、文档审核、案件管理及法律工作流自动化等工具,服务客户包括律师事务所、企业法务部门及政府法律机构。
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
LAW vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.8倍
$41.2M
营收增速更快
PBYI
高出16.4%
11.3%
自由现金流更多
PBYI
多$14.1M
$255.0K
两年增速更快
PBYI
近两年复合增速
7.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $41.2M | $75.5M |
| 净利润 | $-8.5M | — |
| 毛利率 | 75.1% | 69.3% |
| 营业利润率 | -22.4% | 22.7% |
| 净利率 | -20.7% | — |
| 营收同比 | 11.3% | 27.7% |
| 净利润同比 | 66.3% | — |
| 每股收益(稀释后) | $-0.13 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LAW
PBYI
| Q4 25 | $41.2M | $75.5M | ||
| Q3 25 | $40.9M | $54.5M | ||
| Q2 25 | $38.1M | $52.4M | ||
| Q1 25 | $36.7M | $46.0M | ||
| Q4 24 | $37.0M | $59.1M | ||
| Q3 24 | $36.3M | $80.5M | ||
| Q2 24 | $36.0M | $47.1M | ||
| Q1 24 | $35.6M | $43.8M |
净利润
LAW
PBYI
| Q4 25 | $-8.5M | — | ||
| Q3 25 | $-13.7M | $8.8M | ||
| Q2 25 | $-10.8M | $5.9M | ||
| Q1 25 | $-11.4M | $3.0M | ||
| Q4 24 | $-25.2M | — | ||
| Q3 24 | $-9.2M | $20.3M | ||
| Q2 24 | $-10.8M | $-4.5M | ||
| Q1 24 | $-10.6M | $-4.8M |
毛利率
LAW
PBYI
| Q4 25 | 75.1% | 69.3% | ||
| Q3 25 | 75.5% | 77.7% | ||
| Q2 25 | 74.6% | 76.5% | ||
| Q1 25 | 74.1% | 77.1% | ||
| Q4 24 | 74.2% | 76.4% | ||
| Q3 24 | 73.1% | 63.9% | ||
| Q2 24 | 74.2% | 77.4% | ||
| Q1 24 | 75.1% | 75.5% |
营业利润率
LAW
PBYI
| Q4 25 | -22.4% | 22.7% | ||
| Q3 25 | -35.3% | 17.6% | ||
| Q2 25 | -31.0% | 12.7% | ||
| Q1 25 | -34.4% | 8.7% | ||
| Q4 24 | -70.6% | 22.6% | ||
| Q3 24 | -30.0% | 27.4% | ||
| Q2 24 | -34.4% | -4.6% | ||
| Q1 24 | -34.7% | -5.3% |
净利率
LAW
PBYI
| Q4 25 | -20.7% | — | ||
| Q3 25 | -33.4% | 16.2% | ||
| Q2 25 | -28.4% | 11.2% | ||
| Q1 25 | -31.1% | 6.5% | ||
| Q4 24 | -68.1% | — | ||
| Q3 24 | -25.3% | 25.2% | ||
| Q2 24 | -30.1% | -9.6% | ||
| Q1 24 | -29.7% | -11.0% |
每股收益(稀释后)
LAW
PBYI
| Q4 25 | $-0.13 | $0.26 | ||
| Q3 25 | $-0.22 | $0.17 | ||
| Q2 25 | $-0.18 | $0.12 | ||
| Q1 25 | $-0.19 | $0.06 | ||
| Q4 24 | $-0.43 | $0.40 | ||
| Q3 24 | $-0.15 | $0.41 | ||
| Q2 24 | $-0.18 | $-0.09 | ||
| Q1 24 | $-0.17 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $114.6M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $128.1M | $130.3M |
| 总资产 | $173.6M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势,按日历期对齐
现金及短期投资
LAW
PBYI
| Q4 25 | $114.6M | $97.5M | ||
| Q3 25 | $113.5M | $94.4M | ||
| Q2 25 | $114.5M | $96.0M | ||
| Q1 25 | $118.8M | $93.2M | ||
| Q4 24 | $129.1M | $101.0M | ||
| Q3 24 | $126.8M | $96.7M | ||
| Q2 24 | $130.0M | $96.8M | ||
| Q1 24 | $148.7M | $107.2M |
总债务
LAW
PBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益
LAW
PBYI
| Q4 25 | $128.1M | $130.3M | ||
| Q3 25 | $130.6M | $115.3M | ||
| Q2 25 | $137.9M | $104.7M | ||
| Q1 25 | $142.2M | $97.1M | ||
| Q4 24 | $147.5M | $92.1M | ||
| Q3 24 | $167.3M | $71.1M | ||
| Q2 24 | $170.9M | $48.5M | ||
| Q1 24 | $193.2M | $51.0M |
总资产
LAW
PBYI
| Q4 25 | $173.6M | $216.3M | ||
| Q3 25 | $174.8M | $202.9M | ||
| Q2 25 | $164.9M | $194.9M | ||
| Q1 25 | $168.0M | $196.2M | ||
| Q4 24 | $180.3M | $213.3M | ||
| Q3 24 | $194.4M | $220.7M | ||
| Q2 24 | $198.0M | $205.0M | ||
| Q1 24 | $217.3M | $214.1M |
负债/权益比
LAW
PBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $762.0K | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $255.0K | $14.4M |
| 自由现金流率自由现金流/营收 | 0.6% | 19.1% |
| 资本支出强度资本支出/营收 | 1.2% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-18.0M | $41.7M |
8季度趋势,按日历期对齐
经营现金流
LAW
PBYI
| Q4 25 | $762.0K | $14.4M | ||
| Q3 25 | $-979.0K | $9.7M | ||
| Q2 25 | $-4.2M | $14.1M | ||
| Q1 25 | $-10.5M | $3.6M | ||
| Q4 24 | $2.1M | $15.6M | ||
| Q3 24 | $-2.9M | $11.0M | ||
| Q2 24 | $-650.0K | $1.0M | ||
| Q1 24 | $-7.3M | $11.2M |
自由现金流
LAW
PBYI
| Q4 25 | $255.0K | $14.4M | ||
| Q3 25 | $-2.0M | $9.7M | ||
| Q2 25 | $-5.2M | $14.1M | ||
| Q1 25 | $-11.0M | $3.6M | ||
| Q4 24 | $1.5M | $15.6M | ||
| Q3 24 | $-3.7M | $11.0M | ||
| Q2 24 | $-1.3M | $1.0M | ||
| Q1 24 | $-8.0M | — |
自由现金流率
LAW
PBYI
| Q4 25 | 0.6% | 19.1% | ||
| Q3 25 | -5.0% | 17.7% | ||
| Q2 25 | -13.6% | 26.8% | ||
| Q1 25 | -30.1% | 7.7% | ||
| Q4 24 | 4.1% | 26.4% | ||
| Q3 24 | -10.3% | 13.7% | ||
| Q2 24 | -3.6% | 2.1% | ||
| Q1 24 | -22.5% | — |
资本支出强度
LAW
PBYI
| Q4 25 | 1.2% | 0.0% | ||
| Q3 25 | 2.6% | 0.0% | ||
| Q2 25 | 2.5% | 0.0% | ||
| Q1 25 | 1.4% | 0.1% | ||
| Q4 24 | 1.5% | 0.0% | ||
| Q3 24 | 2.4% | 0.0% | ||
| Q2 24 | 1.8% | 0.0% | ||
| Q1 24 | 1.9% | 0.0% |
现金转化率
LAW
PBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAW
| Software | $35.1M | 85% |
| Services | $6.0M | 15% |
PBYI
暂无分部数据